A detailed history of Black Rock Inc. transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 9,046,144 shares of SANA stock, worth $49 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,046,144
Previous 8,469,222 6.81%
Holding current value
$49 Million
Previous $34.6 Million 161.8%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$4.2 - $11.27 $2.42 Million - $6.5 Million
576,922 Added 6.81%
9,046,144 $90.5 Million
Q4 2023

Feb 13, 2024

BUY
$2.8 - $4.55 $1.33 Million - $2.16 Million
475,259 Added 5.95%
8,469,222 $34.6 Million
Q3 2023

Nov 13, 2023

BUY
$3.77 - $6.23 $411,631 - $680,228
109,186 Added 1.38%
7,993,963 $30.9 Million
Q2 2023

Aug 11, 2023

BUY
$3.22 - $7.53 $267,099 - $624,613
82,950 Added 1.06%
7,884,777 $47 Million
Q1 2023

May 12, 2023

BUY
$3.11 - $4.92 $51,240 - $81,061
16,476 Added 0.21%
7,801,827 $25.5 Million
Q4 2022

Feb 13, 2023

BUY
$3.19 - $6.46 $2.63 Million - $5.33 Million
824,894 Added 11.85%
7,785,351 $30.8 Million
Q3 2022

Nov 14, 2022

SELL
$5.58 - $9.04 $194,585 - $315,242
-34,872 Reduced 0.5%
6,960,457 $41.8 Million
Q2 2022

Aug 12, 2022

BUY
$4.12 - $9.35 $2.16 Million - $4.9 Million
524,453 Added 8.1%
6,995,329 $45 Million
Q1 2022

May 12, 2022

BUY
$5.24 - $15.58 $2.62 Million - $7.79 Million
500,173 Added 8.38%
6,470,876 $53.5 Million
Q4 2021

Feb 10, 2022

BUY
$15.18 - $23.15 $13.2 Million - $20.2 Million
872,033 Added 17.1%
5,970,703 $92.4 Million
Q3 2021

Nov 09, 2021

BUY
$16.29 - $25.88 $53.5 Million - $85 Million
3,283,779 Added 180.94%
5,098,670 $115 Million
Q2 2021

Aug 11, 2021

BUY
$16.65 - $32.14 $30.2 Million - $58.3 Million
1,814,891 New
1,814,891 $35.7 Million

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $1.03B
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.